References
- La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113–130.
- Reichman DE, Goldschlag D, Rosenwaks Z. Value of anti-Mullerian hormone as a prognostic indicator of in vitro fertilization outcome. Fertil Steril. 2014; 10:1012–1018.
- Lambert-Messerlian G, Plante B, Eklund EE, et al. Levels of anti-Müllerian hormone in serum during the normal menstrual cycle. Fertil Steril. 2016;105(1):208–213.
- Li HW, Lee VC, Lau EY, et al. Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. PLoS One. 2013;238:e61095.
- Khader A, Lloyd SM, McConnachie A, et al. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6(1):3.
- Iliodromiti S, Kelsey TW, Wu O, et al. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20(4):560–570.
- La Marca A, Spada E, Grisendi V, et al. Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reprod Biol. 2012;163(2):180–184.
- Yavas Y. Curvilinear relationship between age and assisted reproduction technique success: retrospective analyses of US National ART Surveillance System data from 2010-2014. Reprod Biomed Online. 2017;35(6):657–668.
- Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656–663.
- Scheffer JB, Scheffer BB, de Carvalho RF, et al. Age as a predictor of embryo quality regardless of the quantitative ovarian response. Int J Fertil Steril. 2017;11(1):40–46.
- Wesselink AK, Rothman KJ, Hatch EE, et al. Age and fecundability in a North American preconception cohort study. Am J Obstet Gynecol. 2017;217(6):667.e1–8.
- van Tilborg TC, Oudshoorn SC, Eijkemans MJC; on behalf of the OPTIMIST study group, et al. OPTIMIST study group. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. Hum Reprod. 2017;32(12):2485–2495.
- La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124–140.
- Nelson SM, Yates RW, Lyall H, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2008;24(4):867–875.
- Pacheco A, Cruz M, García Velasco JA. Impact of very low anti-Müllerian hormone on pregnancy success. Curr Opin Obstet Gynecol. 2017;29(3):131–135.
- Honma H, Baba T, Sasaki M, et al. Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization. J Assist Reprod Genet. 2012;29:117–125.
- Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21(6):698–710.
- Grynnerup AG, Løssl K, Pilsgaard F, et al. Prediction of the lower serum antiMüllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study. Reprod Biol Endocrinol. 2019;17(1):11.
- Seifer DB, Tal O, Wantman E, et al. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum anti-Müllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril. 2016;105:385–393.e3.
- Revelli A, Biasoni V, Gennarelli G, et al. IVF results in patients with very low serum AMH are significantly affected by chronological age. J Assist Reprod Genet. 2016;33(5):603–609.
- Lukaszuk K, Kunicki M, Liss J, et al. Probability of live birth in women with extremely low anti-Müllerian hormone concentrations. Reprod Biomed Online. 2014; 28:64–69.
- Kedem A, Haas J, Geva LL, et al. Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles. PLoS One. 2013;8(12):e81629.